Related Experiment Videos
Cardiovascular activity of aromatic guanidine compounds
Journal of Medicinal Chemistry
|November 1, 1975
Summary
Researchers explored aromatic guanidines and phenylbiguanides for cardiovascular effects. The most potent compounds caused vasoconstriction, potentially via an alpha-adrenergic mechanism, offering insights into cardiovascular drug development.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Cardiovascular Science
Background:
- Aromatic guanidines and phenylbiguanides are classes of compounds with potential biological activity.
- Understanding their cardiovascular effects is crucial for developing new therapeutic agents.
Purpose of the Study:
- To synthesize and evaluate the cardiovascular (CV) effects of aromatic guanidines and 1-phenylbiguanides.
- To explore structure-activity relationships (SAR) and preliminary mechanisms of action.
Main Methods:
- Cardiovascular parameters (heart rate, blood pressure, carotid artery blood flow, myocardial force) were measured in anesthetized dogs.
- Synthesis of aromatic guanidines and 1-phenylbiguanides.
- Structure-activity relationship analysis and preliminary mechanism studies.
Main Results:
- The predominant CV effect observed was vasoconstriction, independent of cardiac stimulation.
- Phenylguanidines with hydroxy or chloro substituents at the 3 and 4 positions were the most potent.
- Preliminary studies suggested a direct alpha-adrenergic mechanism for 3,4-dihydroxyphenylguanidines.
Conclusions:
- Aromatic guanidines and phenylbiguanides exhibit significant cardiovascular effects, primarily vasoconstriction.
- Specific structural features, such as 3,4-disubstitution on the phenyl ring, enhance potency.
- The alpha-adrenergic system is implicated in the mechanism of action for some of these compounds.